All In Biotech

Drug Trial Radar · NCT06858696

A Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic Function

An Open-label, Non-randomized Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic Function

Last checked: Nov 19, 2026Latest source record: Jul 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

39

Actual

Start

Feb 28, 2025

Primary completion

Jan 12, 2026

Study completion Jan 12, 2026

Sponsor

Lead sponsor
X4 PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Mar 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to measure the effect of HI on the PK, safety, and tolerability of a single dose of mavorixafor compared to matched healthy volunteers (HVs) with normal hepatic function.

Conditions

  • Hepatic Insufficiency

Interventions

  • MavorixaforDrug

    Mavorixafor will be administered per schedule specified in the arm description.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Observed Plasma Concentration (Cmax) of MavorixaforTime frame: Predose up to 192 hours postdose (Day 1 up to Day 9)
  2. Area Under the Serum Concentration Curve From Time Zero to the Last Measurable Concentration (AUC0-last) of MavorixaforTime frame: Predose up to 192 hours postdose (Day 1 up to Day 9)

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Catalina Research Institute, LLC

    Montclair, California

  • Catalina Research Institute, LLC

    Rialto, California

  • Orlando Clinical Research Center

    Orlando, Florida

  • Texas Liver Institute/Alamo Medical Research

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.